In-hospital prognostic value of admission plasma B-type natriuretic peptide levels in patients undergoing primary angioplasty for acute ST-elevation myocardial infarction

Turk Kardiyoloji Dernegi Arsivi

Volumn 39, Issue 7, 2011, Pages 540-548

  Oduncu, Vecih ^a   Erkol, Ayhan ^a,b   Tanalp, Ali Cevat ^a,c   Dündar, Cihan ^a   Tanboǧa, Ibrahim Halil ^a,d   Sirma, Dicle ^a,e   Karagöz, Ali ^a   Karabay, Can Yücel ^a   Izgi, Akin ^a   Pala, Selçuk ^a   Tigen, Kürşat ^a   Kirma, Cevat ^a  

^a KOSUYOLU HEART AND RESEARCH HOSPITAL   (Turkey)

^b Kocaeli Derince Training and Research Hospital   (Turkey)

^c Medicana International Hospital   (Turkey)

^d Erzurum Training and Research Hospital   (Turkey)

^e SIIRT STATE HOSPITAL   (Turkey)

Author keywords

Angioplasty, balloon, coronary; Coronary angiography; Myocardial infarction; Natriuretic peptide, brain; Prognosis; Risk assessment

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; CLOPIDOGREL; HEPARIN; TIROFIBAN;

ADULT; ANGIOGRAPHY; ANGIOPLASTY; ARTICLE; FEMALE; HEART FAILURE; HEART REINFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ANTERIOR MYOCARDIAL INFARCTION; BLOOD; EVALUATION; HOSPITALIZATION; MIDDLE AGED; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, BALLOON, CORONARY; ANTERIOR WALL MYOCARDIAL INFARCTION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84555196279     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: 10.5543/tkda.2011.01610     Document Type: Article

References (28)

1. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation 2000;102:3074-9.
2. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol 1996; 27:1656-61. (Pubitemid 26198017)
3. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003;107:2786-92. (Pubitemid 36705987)
4. Mega JL, Morrow DA, De Lemos JA, Sabatine MS, Murphy SA, Rifai N, et al. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004;44:335-9. (Pubitemid 38950592)
5. Grabowski M, Filipiak KJ, Karpinski G, Wretowski D, Rdzanek A, Huczek Z, et al. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Am Heart J 2004;148:655-62. (Pubitemid 39349386)
6. Jeong YH, Kim WJ, Park DW, Choi BR, Lee SW, Kim YH, et al. Serum B-type natriuretic peptide on admission can predict the 'no-reflow' phenomenon after primary drug-eluting stent implantation for ST-segment elevation myocardial infarction. Int J Cardiol 2010;141:175-81.
7. Daniels LB, Allison MA, Clopton P, Redwine L, Siecke N, Taylor K, et al. Use of natriuretic peptides in pre-participation screening of college athletes. Int J Cardiol 2008; 124:411-4. (Pubitemid 351305374)
8. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. (Pubitemid 34764819)
9. Wu AH, Packer M, Smith A, Bijou R, Fink D, Mair J, et al. Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 2004;50:867-73. (Pubitemid 38543665)
10. World Health Organization. Nutritional anemias: Report of a WHO Scientific Group. Geneva: World Health Organization; 1968.
11. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70. (Pubitemid 29135798)
12. Morrow DA, Antman EM, Charlesworth A, Cairns R, Murphy SA, de Lemos JA, et al. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of Infarcting Myocardium Early II trial substudy. Circulation 2000;102:2031-7.
13. van 't Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation 1998;97:2302-6. (Pubitemid 28280383)
14. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985;5:587-92. (Pubitemid 15141963)
15. de Lemos JA, Braunwald E. ST segment resolution as a tool for assessing the efficacy of reperfusion therapy. J Am Coll Cardiol 2001;38:1283-94. (Pubitemid 33032999)
16. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-9.
17. Reffelmann T, Kloner RA. The "no-reflow" phenomenon: basic science and clinical correlates. Heart 2002;87:162-8. (Pubitemid 34098385)
18. Hong SN, Ahn Y, Hwang SH, Yoon NS, Lee SR, Moon JY, et al. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2007;100:631-4. (Pubitemid 47223139)
19. Goetze JP, Christoffersen C, Perko M, Arendrup H, Rehfeld JF, Kastrup J, et al. Increased cardiac BNP expression associated with myocardial ischemia. FASEB J 2003;17:1105-7.
20. Palazzuoli A, Gennari L, Calabria P, Quatrini I, Vecchiato L, De Paola V, et al. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries. Am J Cardiol 2005;96:1705-10. (Pubitemid 41790395)
21. Sadanandan S, Cannon CP, Chekuri K, Murphy SA, Dibattiste PM, Morrow DA, et al. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004;44:564-8. (Pubitemid 39078180)
22. Bruder O, Jensen C, Jochims M, Farazandeh M, Barkhausen J, Schlosser T, et al. Relation of B-type natriuretic peptide (BNP) and infarct size as assessed by contrast-enhanced MRI. Int J Cardiol 2010;144:53-8.
23. Paelinck BP, Vrints CJ, Bax JJ, Bosmans JM, De Hert SG, de Roos A, et al. Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging. Am J Cardiol 2006;97:1146-50.
24. Cerisano G, Pucci PD, Sulla A, Tommasi M, Raspanti S, Santoro GM, et al. Relation between plasma brain natriuretic peptide, serum indexes of collagen type I turnover, and left ventricular remodeling after reperfused acute myocardial infarction. Am J Cardiol 2007;99: 651-6.
25. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, et al. Plasma brain natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodeling after acute myocardial infarction. Am Heart J 1998;135:21-8. (Pubitemid 28073054)
26. Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Demopoulos LA, DiBattiste PM, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/ non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003;41:1264-72. (Pubitemid 36438985)
27. Grabowski M, Filipiak KJ, Malek LA, Karpinski G, Huczek Z, Stolarz P, et al. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty. Int J Cardiol 2007;115:386-90. (Pubitemid 46185640)
28. Ang DS, Kong CF, Kao MP, Struthers AD. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities. Am Heart J 2009;158:133-40.